Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains

H Tamamura, Y Koh, S Ueda, Y Sasaki…

Index: Journal of Medicinal Chemistry, , vol. 46, # 9 p. 1764 - 1768

Full Text: HTML

Citation Number: 43

Abstract

... Journal of Medicinal Chemistry. ... II, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan; Yokohama Laboratory, SC BioSciences Corporation, Hodogaya-ku, Yokohama 240-0005, Japan; and Experimental Retrovirology Section, Medicine Branch, Division of ...

Related Articles:

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664]

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664]

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Journal of Organic Chemistry, , vol. 59, # 13 p. 3656 - 3664]

The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors

[Journal of Medicinal Chemistry, , vol. 37, # 8 p. 1177 - 1188]

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664]

More Articles...